✨ Education and Health Notices




9 FEBRUARY 2012 NEW ZEALAND GAZETTE, No. 14

A copy of the supplementary integration agreement is available for inspection without charge by any member of the public via the following email address:

enquiries.whangarei@minedu.govt.nz

Dated at Wellington this 2nd day of February 2012.

JEREMY WOOD, Group Manager, Education, Curriculum and Performance.

go650

Supplementary Integration Agreement

Pursuant to section 10 of the Private Schools Conditional Integration Act 1975, notice is given that a supplementary integration agreement has been signed between the Minister of Education on behalf of Her Majesty The Queen, acting through the Group Manager, Education, Curriculum and Performance, Ministry of Education, pursuant to delegated authority, and the proprietor of the following school:

Rosmini College, Takapuna (39).

The said supplementary integration agreement was executed on 13 January 2012.

A copy of the supplementary integration agreement is available for inspection without charge by any member of the public via the following email address:

enquiries.auckland@minedu.govt.nz

Dated at Wellington this 30th day of January 2012.

JEREMY WOOD, Group Manager, Education, Curriculum and Performance.

go649

Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Arrow - Latanoprost
Active Ingredient: Latanoprost 0.05mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturers: Catalent Pharma Solutions LLC, Illinois, United States of America
SIFI S.p.A, Antonio, Italy

Product: Blackmores Flexagil Pain Relief Cream
Active Ingredient: Symphytum officinale 350mg/g
Dosage Form: Topical cream
New Zealand Sponsor: Blackmores (NZ) Limited
Manufacturer: Merck KGaA & Co, Spittal/Drau, Austria

Product: Exjade
Active Ingredient: Deferasirox 125mg
Dosage Form: Dispersible tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland

Product: Exjade
Active Ingredient: Deferasirox 250mg
Dosage Form: Dispersible tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland

Product: Exjade
Active Ingredient: Deferasirox 500mg
Dosage Form: Dispersible tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland

Product: Meropenem Ranbaxy
Active Ingredient: Meropenem trihydrate 570mg equivalent to Meropenem 500mg
Dosage Form: Powder for injection
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Ranbaxy Laboratories Limited, Madhya Pradesh, India



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2012, No 14





✨ LLM interpretation of page content

πŸŽ“ Supplementary Integration Agreement (continued from previous page)

πŸŽ“ Education, Culture & Science
2 February 2012
Private Schools, Integration, Rosmini College, Takapuna
  • JEREMY WOOD, Group Manager, Education, Curriculum and Performance

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
Medicines, Distribution, Medicines Act 1981, Arrow Pharmaceuticals, Blackmores, Novartis, Douglas Pharmaceuticals